Epidemiology of Surgical-Site Infections Diagnosed After Hospital Discharge A Prospective Cohort Study

2001 ◽  
Vol 22 (1) ◽  
pp. 24-30 ◽  
Author(s):  
Miguel Delgado-Rodríguez ◽  
Antonio Gómez-Ortega ◽  
Maria Sillero-Arenas ◽  
Javier Llorca

AbstractObjective:To study postoperative infections in hospital and after discharge, and to identify the risk factors for such infections.Design:Prospective cohort study, with telephone follow-up for 1 month after hospital discharge.Setting:The general surgery service of a tertiary hospital in Spain.Main Outcome Measure:In-hospital and postdischarge surgical-site infection (SSI), always confirmed by a physician.Results:Of the 1,506 patients initially enrolled, 29 died during hospital stay, and 33 were lost to postdischarge follow-up. An SSI was identified prior to discharge in 123 patients and after discharge in 103. For several variables (age, serum albumin, glycemia, lengths of preoperative and postoperative hospital stay, etc), there were no differences between patients with postdischarge SSI and noninfected patients; however, there were differences detected between patients with postdischarge SSI and in-hospital SSI, as well as between patients with in-hospital SSI and noninfected patients. The analysis of risk factors showed that most predictors for in-hospital SSI did not behave in the same manner for postdischarge SSI. Stepwise logistic regression only identified chemoprophylaxis, age (advanced age was a preventive factor), and body mass index as independent risk factors for postdischarge SSI. Differences in risk factors between in-hospital and postdischarge SSIs remained even after controlling for time from operation to diagnosis.Conclusions:Most predictors of in-hospital SSI were not predictors of postdischarge SSI.

2010 ◽  
Vol 163 (4) ◽  
pp. 699-708 ◽  
Author(s):  
Caroline Sievers ◽  
Jens Klotsche ◽  
Lars Pieper ◽  
Harald J Schneider ◽  
Winfried März ◽  
...  

ObjectiveAlthough associations between testosterone and cardiovascular (CV) morbidity in women have been proposed, no large prospective study has evaluated potential associations between testosterone and mortality in women. The objective was to determine whether baseline testosterone levels in women are associated with future overall or CV morbidity and mortality.DesignProspective cohort study with a 4.5-year follow-up period.MethodsFrom a representative sample of German primary care practices, 2914 female patients between 18 and 75 years were analyzed for the main outcome measures: CV risk factors, CV diseases, and all-cause mortality.ResultsAt baseline, the study population was aged 57.96±14.37 years with a mean body mass index of 26.71±5.17 kg/m2. No predictive value of total testosterone for incident CV risk factors or CV diseases was observed in logistic regressions. Patients with total testosterone levels in the lowest quintile Q1, however, had a higher risk to die of any cause or to develop a CV event within the follow-up period compared to patients in the collapsed quintiles Q2–Q5 in crude and adjusted Cox regression models (all-cause mortality: Q2–Q5 versus Q1: crude hazard ratios (HR) 0.49, 95% confidence interval (CI) 0.33–0.74; adjusted HR 0.62, 95% CI 0.42–0.939; CV events: Q2–Q5 versus Q1: crude HR 0.54, 95% CI 0.38–0.77; adjusted HR 0.68, 95% CI 0.48–0.97). Kaplan–Meier curves revealed similar data.ConclusionsLow baseline testosterone in women is associated with increased all-cause mortality and incident CV events independent of traditional risk factors.


2019 ◽  
Vol 27 (11) ◽  
pp. 4133-4144 ◽  
Author(s):  
Miren Orive ◽  
◽  
Urko Aguirre ◽  
Nerea Gonzalez ◽  
Santiago Lázaro ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document